Mario VENDITTI

full professor of medicine and Infectious diseases

Università degli Studi di Roma La Sapienza

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Microbiology Microbiology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Mario Venditti is a full professor of medicine and infectious diseases at Università degli Studi di Roma La Sapienza, Italy. His research focuses on various aspects of infectious diseases, including oxidative stress in COVID-19, antibiotic stewardship, and the epidemiology of invasive Candida infections. His recent publications address critical issues such as antimicrobial treatment strategies and the reliability of biomarkers in critically ill patients.

Articles (14)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (17)

PAOLO MARTINI

Sapienza University of Rome

ITALY

Mario VENDITTI

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19

Short Course Antibiotic Therapy for Catheter-Related Septic Thrombosis: “Caveat Emptor!”: Duration of Therapy Should Not Be Set a Priori

High Incidence of Candidemia in Critically Ill COVID-19 Patients Supported by Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study

Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin

Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin

Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint Implant–Related Infections

Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin

Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients—Results from a Retrospective Observational Study in Intensive Care Units

New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended

Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma

Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios

Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared

Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report

High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii

Collaborators (17)

PAOLO MARTINI

Roberto Carnevale

pasquale pignatelli

Valentina Baccolini

Alessandro Russo

Carlo Tascini

Francesco PUGLIESE

VITTORIO PICCHIO

Claudio Maria MASTROIANNI

GIULIA CARLA MARCHETTI

Emanuele Durante-Mangoni

Alessandra Oliva

Gabriella d'Ettorre

Giacomo Frati

Daniele De Meo

Alessandra Carattoli

Federico Pea

Make your next move.